21st Closed Scientific Expert Meeting of the Editorial Board
AZD0780: A small molecule inhibitor of PCSK9 – Early clinical data
Reports from the 21st Virtual Closed Scientific Expert Meeting of the Editorial Board Rick Vega
read more »Posted on 23 October 2024 |
Posted by Rick Vega | Posted in Hot topics,
21st Closed Scientific Expert Meeting of the Editorial Board
Lerodalcibep, a third generation PCSK9 inhibitor: Overview of completed phase 3 programme
Reports from the 21st Virtual Closed Scientific Expert Meeting of the Editorial Board Dirk Blom
read more »Posted on 23 October 2024 |
Posted by Dirk Blom | Posted in Hot topics,
21st Closed Scientific Expert Meeting of the Editorial Board
The trajectory of ASCVD: Focus on subclinical atherosclerosis
Reports from the 21st Virtual Closed Scientific Expert Meeting of the Editorial Board Borja Ibanez
read more »Posted on 23 October 2024 |
Posted by Borja Ibanez | Posted in Hot topics,
21st Closed Scientific Expert Meeting of the Editorial Board